These findings suggest that monitoring MMP-1 and TIMP-1 levels may provide important information about the ongoing adverse processes of arterial and left ventricular remodeling and fibrosis in patients with HTN [9,17,18,19,20]. Here, MMP1 is linked to hypertensive disorder.